Home > Insider Trading > Filing (0001181431-11-036810)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Transcept Pharmaceuticals Inc	TSPT	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1235962	E Marilyn Wortzman	C/O Transcept Pharmaceuticals, Inc. 1003 W. Cutting Blvd, Suite 110 Point Richmond CA 94804	Vp, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-06-15	4,000	$1.77	4,217	No	4	M	Direct
Common Stock	Disposition	2011-06-15	4,000	$10.11	217	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2011-06-15	4,000	$0.00	4,000	$1.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,027		2017-04-04	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2010.
The sale price reported in column 4 of Table 1 represents the weighted average sales price of the shares sold ranging from $10.07 to $10.15 per share. Upon request of the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
One-fourth of the shares subject to the option vested on March 16, 2008 and one forty-eighth of the shares shall vest monthly thereafter.